Category

Search Reports

Filters

Sub Category

Geography

Publish Date

North America Antibody Drug Conjugates Market Size, Share, and Trends by Target (CD 30, CD 22, HER 2....

The North America antibody-drug conjugates (ADCs) market is expected to reach a market size of $5,619.220 million by 2024 with a CAGR of 27.33%. The market is propelled to grow during the forecast period owing to the extensive research which is being carried out by the big companies situated in this region to find an effective cure for several malignancies, haematological and non-haematological. The growing health expenditure is further contributing to the market growth in the forecast period Read more...

$2,763 Sample Request

Asia Pacific Antibody Drug Conjugates Market Size, Share, Opportunities, and Trends by Target (CD 30....

The Asia Pacific antibody-drug conjugates (ADCs) market is expected to grow at a CAGR of 27.64% to reach a market size of USD2,271.411 million by the end of 2024. Antibody-drug conjugates are the novel and emerging class of anti-cancer therapies consisting of empowered monoclonal antibodies (mAbs) designed to harness the targeting ability of monoclonal antibodies by linking them to cell-killing agents. They consist of covalently linked monoclonal antibodies to small molecule drugs that target Read more...

$2,763 Sample Request

Europe Antibody Drug Conjugates Market Size, Share, and Trends by Target (CD 30, CD 22, HER 2), by I....

The Europe antibody-drug conjugates (ADCs) market is expected to grow at a CAGR of 23.87% to reach a market size of USD2,421.585 million by the end of 2024. The market for antibody-drug conjugates is poised to grow at a rapid pace in the European region with the growing innovations in biotechnology leading to the formation of highly potent pharmaceutical drugs in the forecast period and in the coming years. Also, several companies based in this region are working on the development of highly p Read more...

$2,763 Sample Request

USA Antibody Drug Conjugates Market Size, Share, Opportunities, and Trends by Target (CD 30, CD 22, ....

The USA antibody-drug conjugates (ADCs) market is expected to grow with a CAGR of 27.51 percent to achieve a market size of USD5,318.400 million by the end of 2024. The antibody-drug conjugate technology provides a promising and effective strategy for targeted cancer treatment, hence promoting market growth during the forecast period in the United States. The Seattle Genetics, which is a biotechnology company headquartered in Bothell, Washington has an antibody-drug conjugate drug named as ADC Read more...

$2,338 Sample Request

Genome Editing Market Size, Share, Opportunities, and Trends by Technology (CRISPR, TALEN, ZFN), by ....

Genome Editing market is projected to grow at a CAGR of 12.39% during the forecast period, reaching a total market size of US$6.385 billion in 2024 from US$3.168 billion in 2018. Genome editing or gene editing is a group of technologies that give scientists the ability to change an organism's DNA by adding, removing, or altering genetics. Rising government funding and increasing genomics projects are boosting the growth of the market. The growing prevalence of cancer and other diseases and techn Read more...

$3,358 Sample Request

Tissue Banking Market Size, Share, and Trends by Tissue Type (Cornea, Skin, Bones, Joints, Heart Val....

The Tissue Banking market is projected to grow at a CAGR of 2.69% during the forecast period, reaching a total market size of US$2.774 billion in 2024 from US$2.366 billion in 2018. Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. The market of tissue banking is boosting on account of tremendous advancement in medical research, clinical trials, and biopharmaceutical industries. Increasing investment in the medical and healthcare sector and advances in Read more...

$3,358 Sample Request

Molecular Breeding Market Size, Share, and Trends by Markers (Amplified Fragment Length Polymorphism....

Molecular breeding are used in plant and animal breeding as genes manipulation at DNA level, this is a modern technology which is linked with phenotypic trait and is used as DNA markers to hasten the discharge of improved germplasm. Molecular breeding is mainly used to improve the genetic traits in the DNA to improve the growth of plants and animals. The most important components of molecular breeding are intersimple sequence repeat, amplified fragment length polymorphism and amplified polymo Read more...

$3,358 Sample Request

Platelets Rich Plasma Market Size, Share, Opportunities, And Trends By Type(Pure Platelet-Rich Plasm....

The platelet rich plasma market is estimated to witness a CAGR of 15.34% to grow to US$357.934 million in 2024 from US$152.020 million in 2018. Platelets or thrombocytes are the tiny blood cells that form clots or plug at the site of injury to stop bleeding. They are produced in the bone marrow along with the white and red blood cells. Blood plasma Read more...

$3,358 Sample Request

OUR CLIENTS